Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer

Jae Young Park

doi:10.1016/B978-0-12-809939-1.00013-8

Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer

Jae Young Park

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Regarding the risk of recurrence and progression after optimal treatment, nonmuscle invasive bladder cancer (NMIBC) is classified in three groups such as low, intermediate, and high risk. High-risk NMIBC represents those patients at high probability of recurrence and progression. The American Urological Association considers all T1, high-grade Ta, and carcinoma in situ to be high-risk NMIBC, while the National Comprehensive Cancer Network does all T1. Despite intravesical bacillus Calmette-Guérin (BCG) instillation, long-term follow-up reports certain portion of T1G3 patients treated with BCG instillation showed 45% rate of recurrence and 17% of progression. Risk factors in high-risk NMIBC have been one of the main issues of research in this field recently. Here, various kinds of risk factors for recurrence and progression of NMIBC are described and discussed.

Original language	English
Title of host publication	Bladder Cancer
Publisher	Elsevier Inc.
Pages	187-199
Number of pages	13
ISBN (Electronic)	9780128099407
ISBN (Print)	9780128099391
DOIs	https://doi.org/10.1016/B978-0-12-809939-1.00013-8
Publication status	Published - 2017 Dec 14

Keywords

Nonmuscle invasive bladder cancer
Progression
Recurrence
Risk factors

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-12-809939-1.00013-8

Cite this

@inbook{e37e1c72e78b46d885708131030e6c20,

title = "Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer",

abstract = "Regarding the risk of recurrence and progression after optimal treatment, nonmuscle invasive bladder cancer (NMIBC) is classified in three groups such as low, intermediate, and high risk. High-risk NMIBC represents those patients at high probability of recurrence and progression. The American Urological Association considers all T1, high-grade Ta, and carcinoma in situ to be high-risk NMIBC, while the National Comprehensive Cancer Network does all T1. Despite intravesical bacillus Calmette-Gu{\'e}rin (BCG) instillation, long-term follow-up reports certain portion of T1G3 patients treated with BCG instillation showed 45% rate of recurrence and 17% of progression. Risk factors in high-risk NMIBC have been one of the main issues of research in this field recently. Here, various kinds of risk factors for recurrence and progression of NMIBC are described and discussed.",

keywords = "Nonmuscle invasive bladder cancer, Progression, Recurrence, Risk factors",

author = "Park, {Jae Young}",

year = "2017",

month = dec,

day = "14",

doi = "10.1016/B978-0-12-809939-1.00013-8",

language = "English",

isbn = "9780128099391",

pages = "187--199",

booktitle = "Bladder Cancer",

publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer

AU - Park, Jae Young

PY - 2017/12/14

Y1 - 2017/12/14

N2 - Regarding the risk of recurrence and progression after optimal treatment, nonmuscle invasive bladder cancer (NMIBC) is classified in three groups such as low, intermediate, and high risk. High-risk NMIBC represents those patients at high probability of recurrence and progression. The American Urological Association considers all T1, high-grade Ta, and carcinoma in situ to be high-risk NMIBC, while the National Comprehensive Cancer Network does all T1. Despite intravesical bacillus Calmette-Guérin (BCG) instillation, long-term follow-up reports certain portion of T1G3 patients treated with BCG instillation showed 45% rate of recurrence and 17% of progression. Risk factors in high-risk NMIBC have been one of the main issues of research in this field recently. Here, various kinds of risk factors for recurrence and progression of NMIBC are described and discussed.

AB - Regarding the risk of recurrence and progression after optimal treatment, nonmuscle invasive bladder cancer (NMIBC) is classified in three groups such as low, intermediate, and high risk. High-risk NMIBC represents those patients at high probability of recurrence and progression. The American Urological Association considers all T1, high-grade Ta, and carcinoma in situ to be high-risk NMIBC, while the National Comprehensive Cancer Network does all T1. Despite intravesical bacillus Calmette-Guérin (BCG) instillation, long-term follow-up reports certain portion of T1G3 patients treated with BCG instillation showed 45% rate of recurrence and 17% of progression. Risk factors in high-risk NMIBC have been one of the main issues of research in this field recently. Here, various kinds of risk factors for recurrence and progression of NMIBC are described and discussed.

KW - Nonmuscle invasive bladder cancer

KW - Progression

KW - Recurrence

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85054748373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054748373&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-809939-1.00013-8

DO - 10.1016/B978-0-12-809939-1.00013-8

M3 - Chapter

AN - SCOPUS:85054748373

SN - 9780128099391

SP - 187

EP - 199

BT - Bladder Cancer

PB - Elsevier Inc.

ER -

Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this